Cat.No. | Name | Information |
---|---|---|
M31384 | TPP-1 hydrochloride | TPP-1 hydrochloride is a potent inhibitor of PD-1/PD-L1 interaction and binds specifically to PD-L1 with a Kd value of 95 nM.Can be used in tumor related studies. |
M31382 | Triptorelin acetate | Triptorelin acetate is a synthetic decapeptide analog of luteinizing hormone-releasing hormone (LHRH) and a gonadotropin-releasing hormone (GnRH) agonist. |
M31369 | Beinaglutide TFA | Beinaglutide TFA is a recombinant human GLP-1 (rhGLP-1) peptide and a GLP-1R agonist that can be used in studies related to obesity and non-alcoholic steatohepatitis (NASH). |
M31358 | [Leu15]-Gastrin I (human) | [Leu15]-Gastrin I (human) is a peptide that acts via cholecystokinin (CCK) or CCK-B receptor (CCK-BR). |
M31356 | Iberiotoxin TFA | Iberiotoxin TFA is also a selective, high-affinity blocker of the large conductance calcium-activated potassium channel (BKCa) with a Kd of approximately 1 nM. |
M31353 | TAT-GluA2 3Y | TAT-GluA2 3Y is a GluA2-derived interfering peptide that blocks long-term depression (LTD) at glutamatergic synapses by preventing regulated endocytosis of AMPA receptors. |
M31350 | Rusfertide TFA | Rusfertide is a peptide mimetic of hepcidin that can be used in studies related to iron deficiency anemia and true erythrocytosis (PV). |
M31345 | Glepaglutide | Glepaglutide is a novel, long-acting glucagon-like peptide-2 (GLP-2) analog and a potent GLP-2R agonist. Glepaglutide is used in studies related to inflammatory bowel disease (IBD) and Crohn's disease. |
M31341 | Omiganan TFA | Omiganan is a novel synthetic cationic antimicrobial peptide containing 12 amino acids, as well as a synthetic analog of indolemycin, with broad-spectrum antimicrobial and antibiofilm activity. It can be used in studies related to atopic rhinitis. |
M31340 | Peceleganan acetate | Peceleganan (antimicrobial peptide PL-5) is a chemically synthesized, alpha-helical antimicrobial peptide containing 26 amino acid residues. |
M31315 | Sinapultide TFA | Sinapultide is a synthetic peptide that mimics surfactant protein B (SP-B) function and can be used for the modification of synthetic phospholipid surfactants. |
M31297 | WKYMVM acetate | WKYMVM acetate is a potent agonist of the N-formyl peptide receptors FPR1 and FPRL1/2, and also activates a number of leukocyte effector functions such as chemotaxis, activation of complement receptor-3 and NADPH oxidase. |
M31296 | Trp-Lys-Tyr-Met-Val-Met-NH2 | Trp-Lys-Tyr-Met-Val-Met-NH2 (WKYMVm) is a synthetic peptide that is also a specific agonist for formyl peptide-like receptor 1 (FPRL1). |
M31172 | Protease-Activated Receptor-3 (PAR-3) (1-6), human TFA | Protease-Activated Receptor-3 (PAR-3) (1-6), human TFA is an agonist of Protease-Activated Receptor 3 (PAR-3). |
M31169 | Parstatin (mouse) TFA | Parstatin (mouse) TFA is a peptide formed by protein hydrolysis upon PAR1 receptor activation and is also a PAR-1 agonist with cellular permeability. In addition, Parstatin (mouse) TFA is also a potent inhibitor of angiogenesis. It can be used in studies related to ischemia-reperfusion injury. |
M31109 | Gastrin I (rat) TFA | Gastrin I (rat) TFA is a peptide hormone, which can stimulate gastric acid secretion potently. |
M31094 | Retatrutide acetate | Retatrutide (LY3437943) acetate is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide acetate inhibits for human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively. |
M31031 | Apraglutide TFA | Apraglutide TFA (FE 203799 TFA), a synthetic 33-amino-acid peptide and a long-acting GLP-2 analogue, enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum. |
M30885 | Ziconotide acetate | Ziconotide acetate (SNX-111 acetate), a peptide, is a potent and selective block of N-type calcium channels antagonist. Ziconotide acetate reduces synaptic transmission, and can be used for chronic pain research. |
M30861 | Atosiban | Atosiban (RW22164; RWJ22164) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.